The chronic low-grade inflammation indicated by the increased percentage of elevated TNF-α and the elevated concentration of hsCRP in survivors of COVID-19 might partially explain the reduced FMD even nearly 1year after diagnosis. This evidence concerns the gene TNF and COVID-19.